Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Treatment Period	STARTED	Placebo	41
Treatment Period	STARTED	Mipomersen	83
Treatment Period	Full Analysis Set	Placebo	41
Treatment Period	Full Analysis Set	Mipomersen	82
Treatment Period	COMPLETED	Placebo	41
Treatment Period	COMPLETED	Mipomersen	73
Treatment Period	NOT COMPLETED	Placebo	0
Treatment Period	NOT COMPLETED	Mipomersen	10
Follow-up Period	STARTED	Placebo	3
Follow-up Period	STARTED	Mipomersen	28
Follow-up Period	COMPLETED	Placebo	3
Follow-up Period	COMPLETED	Mipomersen	25
Follow-up Period	NOT COMPLETED	Placebo	0
Follow-up Period	NOT COMPLETED	Mipomersen	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00706849/flow